{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:51:00Z","timestamp":1784019060016,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05171-9","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T10:10:04Z","timestamp":1758103804000},"page":"1680-1693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CT-based delta-radiomics nomogram to assess tumor regression grade in locally advanced gastric cancer patients following neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"51","author":[{"given":"Shulan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouliang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"5171_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA A Cancer J Clinicians"},{"key":"5171_CR2","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, et al (2020) Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. IJMS 21:4012. https:\/\/doi.org\/10.3390\/ijms21114012","journal-title":"IJMS"},{"key":"5171_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"S-E Al-Batran","year":"2019","unstructured":"Al-Batran S-E, Homann N, Pauligk C, et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): A randomised, phase 2\/3 trial. The Lancet 393:1948\u20131957. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1","journal-title":"The Lancet"},{"key":"5171_CR4","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"S-E Al-Batran","year":"2016","unstructured":"Al-Batran S-E, Hofheinz RD, Pauligk C, et al (2016) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): Results from the phase 2 part of a multicentre, open-label, randomised phase 2\/3 trial. The Lancet Oncology 17:1697\u20131708. https:\/\/doi.org\/10.1016\/S1470-2045(16)30531-9","journal-title":"The Lancet Oncology"},{"key":"5171_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4251\/wjgo.v12.i1.37","volume":"12","author":"X-Z Wang","year":"2020","unstructured":"Wang X-Z, Zeng Z-Y, Ye X, et al (2020) Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. WJGO 12:37\u201353. https:\/\/doi.org\/10.4251\/wjgo.v12.i1.37","journal-title":"WJGO"},{"key":"5171_CR6","doi-asserted-by":"publisher","first-page":"eaay4211","DOI":"10.1126\/sciadv.aay4211","volume":"6","author":"Z Li","year":"2020","unstructured":"Li Z, Gao X, Peng X, et al (2020) Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy. Sci Adv 6:eaay4211. https:\/\/doi.org\/10.1126\/sciadv.aay4211","journal-title":"Sci Adv"},{"key":"5171_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1470-2045(24)00676-4","volume":"26","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liang H, Li Z, et al (2025) Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): Final report of a randomised, open-label, phase 3 trial. The Lancet Oncology 26:312\u2013319. https:\/\/doi.org\/10.1016\/S1470-2045(24)00676-4","journal-title":"The Lancet Oncology"},{"key":"5171_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4143\/crt.2020.516","volume":"53","author":"Y Tong","year":"2021","unstructured":"Tong Y, Zhu Y, Zhao Y, et al (2021) Evaluation and comparison of predictive value of tumor regression grades according to mandard and becker in locally advanced gastric adenocarcinoma. Cancer Res Treat 53:112\u2013122. https:\/\/doi.org\/10.4143\/crt.2020.516","journal-title":"Cancer Res Treat"},{"key":"5171_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"European Journal of Cancer"},{"key":"5171_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","volume":"25","author":"JK Sicklick","year":"2019","unstructured":"Sicklick JK, Kato S, Okamura R, et al (2019) Molecular profiling of cancer patients enables personalized combination therapy: The I-PREDICT study. Nat Med 25:744\u2013750. https:\/\/doi.org\/10.1038\/s41591-019-0407-5","journal-title":"Nat Med"},{"key":"5171_CR11","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/0008-5472.CAN-22-1183","volume":"82","author":"W Mu","year":"2022","unstructured":"Mu W, Schabath MB, Gillies RJ (2022) Images are data: Challenges and opportunities in the clinical translation of radiomics. Cancer Research 82:2066\u20132068. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1183","journal-title":"Cancer Research"},{"key":"5171_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1148\/radiol.211986","volume":"303","author":"J Shin","year":"2022","unstructured":"Shin J, Seo N, Baek S-E, et al (2022) MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy. Radiology 303:351\u2013358. https:\/\/doi.org\/10.1148\/radiol.211986","journal-title":"Radiology"},{"key":"5171_CR13","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1097\/JS9.0000000000001239","volume":"110","author":"E Abbaspour","year":"2024","unstructured":"Abbaspour E, Karimzadhagh S, Monsef A, et al (2024) Application of radiomics for preoperative prediction of lymph node metastasis in colorectal cancer: A systematic review and meta-analysis. International Journal of Surgery 110:3795\u20133813. https:\/\/doi.org\/10.1097\/JS9.0000000000001239","journal-title":"International Journal of Surgery"},{"key":"5171_CR14","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"Y-J Qi","year":"2024","unstructured":"Qi Y-J, Su G-H, You C, et al (2024) Radiomics in breast cancer: Current advances and future directions. Cell Reports Medicine 5:101719. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101719","journal-title":"Cell Reports Medicine"},{"key":"5171_CR15","doi-asserted-by":"publisher","first-page":"e221291","DOI":"10.1148\/radiol.221291","volume":"307","author":"Z Feng","year":"2023","unstructured":"Feng Z, Li H, Liu Q, et al (2023) CT radiomics to predict macrotrabecular-massive subtype and immune status in hepatocellular carcinoma. Radiology 307:e221291. https:\/\/doi.org\/10.1148\/radiol.221291","journal-title":"Radiology"},{"key":"5171_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000432","author":"C Hu","year":"2023","unstructured":"Hu C, Chen W, Li F, et al (2023) Deep learning radio-clinical signature for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients. International Journal of Surgery Publish Ahead of Print: https:\/\/doi.org\/10.1097\/JS9.0000000000000432","journal-title":"International Journal of Surgery Publish Ahead of Print"},{"key":"5171_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.radonc.2022.04.023","volume":"171","author":"R Song","year":"2022","unstructured":"Song R, Cui Y, Ren J, et al (2022) CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study. Radiotherapy and Oncology 171:155\u2013163. https:\/\/doi.org\/10.1016\/j.radonc.2022.04.023","journal-title":"Radiotherapy and Oncology"},{"key":"5171_CR18","doi-asserted-by":"publisher","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, et al (2020) Development and validation of a preoperative magnetic resonance imaging radiomics\u2013based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open 3:e2028086. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28086","journal-title":"JAMA Netw Open"},{"key":"5171_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jmri.28068","volume":"56","author":"H Jia","year":"2022","unstructured":"Jia H, Jiang X, Zhang K, et al (2022) A nomogram of combining IVIM-DWI and MRI radiomics from the primary lesion of rectal adenocarcinoma to assess nonenlarged lymph node metastasis preoperatively. Magnetic Resonance Imaging 56:658\u2013667. https:\/\/doi.org\/10.1002\/jmri.28068","journal-title":"Magnetic Resonance Imaging"},{"key":"5171_CR20","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1007\/s00330-020-07421-4","volume":"31","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Xu W, Hao D, et al (2021) A CT-based radiomics nomogram for differentiation of lympho-associated benign and malignant lesions of the parotid gland. Eur Radiol 31:2886\u20132895. https:\/\/doi.org\/10.1007\/s00330-020-07421-4","journal-title":"Eur Radiol"},{"key":"5171_CR21","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1097\/JS9.0000000000001337","volume":"110","author":"B Xu","year":"2024","unstructured":"Xu B, Zheng H-L, Chen C, et al (2024) Development and validation of a preoperative radiomics-based nomogram to identify patients who can benefit from splenic hilar lymphadenectomy: A pooled analysis of three prospective trials. International Journal of Surgery 110:4053\u20134061. https:\/\/doi.org\/10.1097\/JS9.0000000000001337","journal-title":"International Journal of Surgery"},{"key":"5171_CR22","doi-asserted-by":"publisher","first-page":"e009616","DOI":"10.1136\/jitc-2024-009616","volume":"12","author":"P Lin","year":"2024","unstructured":"Lin P, Xie W, Li Y, et al (2024) Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma. J Immunother Cancer 12:e009616. https:\/\/doi.org\/10.1136\/jitc-2024-009616","journal-title":"J Immunother Cancer"},{"key":"5171_CR23","doi-asserted-by":"publisher","first-page":"e010723","DOI":"10.1136\/jitc-2024-010723","volume":"13","author":"H Lin","year":"2025","unstructured":"Lin H, Hua J, Wang Y, et al (2025) Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma. J Immunother Cancer 13:e010723. https:\/\/doi.org\/10.1136\/jitc-2024-010723","journal-title":"J Immunother Cancer"},{"key":"5171_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.21037\/jgo-22-537","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xu H, Hu C, et al (2022) Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: A retrospective cohort study. J Gastrointest Oncol 13:1046\u20131057. https:\/\/doi.org\/10.21037\/jgo-22-537","journal-title":"J Gastrointest Oncol"},{"key":"5171_CR25","doi-asserted-by":"publisher","first-page":"758863","DOI":"10.3389\/fonc.2022.758863","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu W, Li Y-L, et al (2022) CT-based radiomics showing generalization to predict tumor regression grade for advanced gastric cancer treated with neoadjuvant chemotherapy. Front Oncol 12:758863. https:\/\/doi.org\/10.3389\/fonc.2022.758863","journal-title":"Front Oncol"},{"key":"5171_CR26","doi-asserted-by":"publisher","first-page":"101348","DOI":"10.1016\/j.eclinm.2022.101348","volume":"46","author":"Y Cui","year":"2022","unstructured":"Cui Y, Zhang J, Li Z, et al (2022) A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study. eClinicalMedicine 46:101348. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101348","journal-title":"eClinicalMedicine"},{"key":"5171_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13244-023-01584-6","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Li L, Chen X, et al (2024) Intratumoral and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer. Insights Imaging 15:23. https:\/\/doi.org\/10.1186\/s13244-023-01584-6","journal-title":"Insights Imaging"},{"key":"5171_CR28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3748\/wjg.v26.i19.2427","volume":"26","author":"Y-H Chen","year":"2020","unstructured":"Chen Y-H, Xiao J, Chen X-J, et al (2020) Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. WJG 26:2427\u20132439. https:\/\/doi.org\/10.3748\/wjg.v26.i19.2427","journal-title":"WJG"},{"key":"5171_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12885-020-06970-7","volume":"20","author":"K-Y Sun","year":"2020","unstructured":"Sun K-Y, Hu H-T, Chen S-L, et al (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20:468. https:\/\/doi.org\/10.1186\/s12885-020-06970-7","journal-title":"BMC Cancer"},{"key":"5171_CR30","doi-asserted-by":"publisher","first-page":"e2121143","DOI":"10.1001\/jamanetworkopen.2021.21143","volume":"4","author":"W Wang","year":"2021","unstructured":"Wang W, Peng Y, Feng X, et al (2021) Development and validation of a computed tomography\u2013based radiomics signature to predict response to neoadjuvant chemotherapy for locally advanced gastric cancer. JAMA Netw Open 4:e2121143. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21143","journal-title":"JAMA Netw Open"},{"key":"5171_CR31","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1007\/s00330-023-10241-x","volume":"34","author":"X Han","year":"2023","unstructured":"Han X, Wang M, Zheng Y, et al (2023) Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Eur Radiol 34:2716\u20132726. https:\/\/doi.org\/10.1007\/s00330-023-10241-x","journal-title":"Eur Radiol"},{"key":"5171_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40644-019-0283-8","volume":"20","author":"P Lin","year":"2020","unstructured":"Lin P, Yang P-F, Chen S, et al (2020) A delta-radiomics model for preoperative evaluation of neoadjuvant chemotherapy response in high-grade osteosarcoma. Cancer Imaging 20:7. https:\/\/doi.org\/10.1186\/s40644-019-0283-8","journal-title":"Cancer Imaging"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05171-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:45:12Z","timestamp":1774352712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["5171"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05171-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7072201\/v1","asserted-by":"object"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}